Search results
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
Zacks via Yahoo Finance Canada· 10 months agoJ&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered...
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging
Zacks via Yahoo Finance Canada· 1 year agoImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug...
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoNet Loss: Reported a net loss of $10.3 million for Q1 2024, slightly above the estimated net loss of $10.44 million. Revenue: Revenue details for Q1 2024 were not provided, unable to compare ...